India Glycols (BOM:500201) EBIT: ₹5,444 Mil (TTM As of Mar. 2026)


BOM:500201 India Glycols Ltd BOM:500201
66 GF Score
Price ₹1,076.15
GF Value ₹752.37
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is India Glycols EBIT?

India Glycols BOM:500201 +4.80% 66 EBIT is ₹5,444 Mil as of Mar. 2026. GuruFocus rates BOM:500201 with a GF Score™ of 66/100 and a GF Value™ of ₹752.37 (Significantly Overvalued). The stock has 2 warning signs investors should review.

India Glycols's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹1,389 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹5,444 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. India Glycols's annualized ROC % for the quarter that ended in Mar. 2026 was 6.19%. India Glycols's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 11.89%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. India Glycols's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 6.18%.

India Glycols  (BOM:500201) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

India Glycols's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=5010.8 * ( 1 - 22.75% )/( (0 + 62513.7)/ 1 )
=3870.843/62513.7
=6.19 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0 - 0 - ( 0 - max(0, 0 - 0+0))
=0

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=65229.5 - 7878.8 - ( 889.3 - max(0, 20141.1 - 14978.1+889.3))
=62513.7

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

India Glycols's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=5554.8/( ( (0 + max(0, 0)) + (45879.9 + max(851.2, 0)) )/ 1 )
=5554.8/( ( 0 + 46731.1 )/ 1 )
=5554.8/46731.1
=11.89 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3514 + 8906.1 + 1668.7) - (7878.8 + 0 + 5358.8)
=851.2

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

India Glycols's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=5443.9/88147.653
=6.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

India Glycols EBIT Related Terms

India Glycols EBIT Historical Data

* Premium members only.

The historical data trend for India Glycols's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

India Glycols EBIT Chart

India Glycols Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,270.03 2,500.17 3,284.39 4,566.90 5,443.90

India Glycols Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,263.20 1,352.10 1,328.90 1,374.20 1,388.70

BOM:500201 vs DOW: EBIT Comparison

For the Chemicals subindustry, India Glycols's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

India Glycols EV-to-EBIT vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, India Glycols's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where India Glycols's EV-to-EBIT falls into.


BOM:500201
66GF Score
India Glycols Ltd BOM:500201
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

India Glycols EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5,444 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹5,444 Mil mean?
India Glycols (BOM:500201) has a EBIT of ₹5,444 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on India Glycols.
Is India Glycols' EBIT too high?
India Glycols' current EBIT is ₹5,444 Mil. Overall, India Glycols has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does India Glycols' EBIT compare to DOW?
India Glycols' EBIT of ₹5,444 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Chemicals company?
A good EBIT depends on the Chemicals industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on India Glycols. India Glycols's current EBIT is ₹5,444 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is India Glycols stock overvalued right now?
Based on GuruFocus' analysis, India Glycols (BOM:500201) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹752.37, compared to a current price of ₹1,076.15 — trading 43% above its estimated fair value. The current EBIT is ₹5,444 Mil. India Glycols' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For India Glycols (BOM:500201), the current EBIT is ₹5,444 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is India Glycols (BOM:500201) Overvalued in 2026?

Based on GuruFocus' analysis, India Glycols stock appears to be overvalued. The current stock price of ₹1,076.15 is trading 43% above its estimated GF Value™ of ₹752.37. GuruFocus considers India Glycols to be Significantly Overvalued.

Key valuation signals for BOM:500201:

  • EBIT: ₹5,444 Mil
  • GF Value™: ₹752.37 vs. price of ₹1,076.15 (43% above fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the BOM:500201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

India Glycols Business Description

Other Exchanges INDIAGLYCO:India
Address Plot No. 2B, Sector - 126, District Gautam Budh Nagar, Noida, UP, IND, 201304
India Glycols Ltd is engaged in the manufacture of Bio-Based Specialities and Performance Chemicals, such as green technology-based bulk products, natural gums, and industrial gases; Potable Spirits, and Ennature Biopharma. The company operates through industries of Pharma & Healthcare, Oil & Gas, Textile, Food Ingredients, Automotive, Packaging, Personal Care, Potable Spirits, and Industrial and Manufacturing. Its operating segments are Bio-based Specialities and Performance Chemicals comprise Glycols, Specialty Chemicals, Natural Gum & other related goods, etc; Potable Spirits comprises the manufacture and sale of Ethyl Alcohol (Potable); Ennature Biopharma comprises the manufacture and sale of Nutraceutical Products; and Bio-fuel comprises Ethanol, DDGS & DWGS.
66GF Score

Get the complete analysis for BOM:500201

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,076.15
Price
₹752.37
GF Value